H1N1 influenza A vaccine (split virion, inactivated), Lanzhou Institute of Biological Products

甲型H1N1流感病毒裂解疫苗(兰州生物制品研究所有限责任公司)

Report date: 2025/04/27 09:04:53

Base Information

Drug NameH1N1 influenza A vaccine (split virion, inactivated), Lanzhou Institute of Biological Products
Drug Alias NameH1N1 influenza A vaccine (split virion, inactivated)
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Application > Prophylactic vaccine +[4
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2009/11/12
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A